The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak-Reference-Cited by-同舟云学术

The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak

Published:2007-12-09 Issue:1 Volume:14 Page:45-54
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Tager Andrew M,LaCamera Peter,Shea Barry S,Campanella Gabriele S,Selman Moisés,Zhao Zhenwen,Polosukhin Vasiliy,Wain John,Karimi-Shah Banu A,Kim Nancy D,Hart William K,Pardo Annie,Blackwell Timothy S,Xu Yan,Chun Jerold,Luster Andrew D

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm1685.pdf

Reference50 articles.

1. Selman, M., King, T.E. & Pardo, A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 134, 136–151 (2001).

2. Martin, P. Wound healing–aiming for perfect skin regeneration. Science 276, 75–81 (1997).

3. Kuhn, C. et al. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am. Rev. Respir. Dis. 140, 1693–1703 (1989).

4. Behr, J. et al. Fibroblast chemotactic response elicited by native bronchoalveolar lavage fluid from patients with fibrosing alveolitis. Thorax 48, 736–742 (1993).

5. Selman, M. et al. Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern. PLoS ONE 2, e482 (2007).

Cited by 679 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Involvement of lysophosphatidic acid-LPA1-YAP signaling in healthy and pathological FAPs migration;Matrix Biology;2024-11

2. GPR176 promotes fibroblast-to-myofibroblast transition in organ fibrosis progression;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-10

3. Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF);Expert Review of Clinical Pharmacology;2024-08-27

4. Imaging Pulmonary Fibrosis and Treatment Efficacy In Vivo with Autotaxin-Specific PET Ligand [¹⁸F]ATX-1905;Molecular Pharmaceutics;2024-08-26

5. MNK-driven eIF4E phosphorylation regulates the fibrogenic transformation of mesenchymal cells and chronic lung allograft dysfunction;Journal of Clinical Investigation;2024-08-15